THC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
5.6B
-2.6%
5.8B
+8.1%
5.3B
-0.1%
5.4B
+1.6%
5.3B
Cost of Revenue
0
0
0
0
0
Gross Profit
5.6B
-2.6%
5.8B
+8.1%
5.3B
-0.1%
5.4B
+1.6%
5.3B
Operating Expenses
4.2B
-6.9%
4.5B
-4.6%
4.8B
+6.5%
4.5B
-0.2%
4.5B
R&D
0
0
0
0
0
SG&A
2.2B
+2.6%
2.2B
-2.2%
2.2B
+0.8%
2.2B
+2.0%
2.2B
Operating Income
1.4B
+12.8%
1.2B
+110.8%
590.0M
-33.6%
889.0M
+11.1%
800.0M
EBITDA
1.2B
-18.7%
1.5B
+66.6%
915.0M
-18.2%
1.1B
+5.6%
1.1B
Net Income
1.0B
+15.3%
906.0M
+40.7%
644.0M
+11.2%
579.0M
+10.9%
522.0M
EPS (Basic)
$9.89
+22.2%
$8.09
+90.4%
$4.25
+9.3%
$3.89
+23.1%
$3.16
EPS (Diluted)
$9.84
+22.8%
$8.01
+89.8%
$4.22
+9.3%
$3.86
+22.9%
$3.14
Shares (Diluted)
84.0M
-4.1%
87.6M
-0.4%
87.9M
-0.8%
88.6M
-3.5%
91.8M
Tenet Healthcare Corporation New (THC) โ€” Financials